PubMed · 7129397
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1982-11-16. Preadmission review programs targeted to reduce utilization.. https://pubmed.ncbi.nlm.nih.gov/7129397/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
Blue Cross of Atlantic Canada has revised its drug-benefit program by restricting the number of drugs eligible for automatic benefits. The program still covers more than 3000 medications, but not items such as nicotine-replacement products, antihistamines, or cough and cold medications. The centrepiece of the revised program is a "special-authorization" process that affects about 140 expensive but "commonly prescribed" drugs such as antidepressant products and medications for migraine treatment. Although may applaud the not-for-profit corporation's intentions, some doctors and patients have experienced difficulty adjusting to the changes.
Explore the source record for details and available documents.